Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy

We evaluated the effect of intravitreal bevacizumab injection (IVB) on choroidal thickness, and studied its association with the therapeutic response in chronic central serous chorioretinopathy (CSC). The clinical features of 78 eyes with chronic CSC treated with IVB from October 2014 to June 2020 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Yoo-Ri, Lee, Su Jeong, Song, Ji Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224583/
https://www.ncbi.nlm.nih.gov/pubmed/35743446
http://dx.doi.org/10.3390/jcm11123375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224583/
https://www.ncbi.nlm.nih.gov/pubmed/35743446
http://dx.doi.org/10.3390/jcm11123375

Ejemplares similares